sulbactam has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldama, L; Bajt, S; Barty, A; Batyuk, A; Boutet, S; Chapman, HN; Feliz, D; Fromme, P; Hayes, B; Hunter, M; Knoska, J; Kupitz, C; Lisova, S; Malla, TN; Mariani, V; Martin-Garcia, JM; Ourmazd, A; Pandey, S; Phillips, GN; Pollack, L; Poudyal, I; Schmidt, M; Schwander, P; Sierra, RG; Stojkovic, EA; Tolstikova, A; Yefanov, O; Yoon, CH; Zielinski, K | 1 |
| Ahmad, MUD; Chikunova, A; Perrakis, A; Safeer, AA; Ubbink, M; van Alen, I | 1 |
2 other study(ies) available for sulbactam and Koch's Disease
| Article | Year |
|---|---|
Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam.
Topics: beta-Lactamases; Humans; Ligands; Mycobacterium tuberculosis; Sulbactam; Tuberculosis | 2023 |
The G132S Mutation Enhances the Resistance of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Point Mutation; Sulbactam; Tuberculosis | 2021 |